Baylor Research Finds First Direct Evidence of Gene-Exposure Link in Gulf War Illness

Operation Desert Storm
(iStockphoto)
Feb. 27, 2015

Follow us on Twitter:@BaylorUMedia

Contact: Tonya B. Lewis, (254) 710-4656

Thousands of service men and women are affected by the condition 24 years later

WACO, Texas (Feb. 27, 2015) — February 28 marks the 24th anniversary of the cease fire that ended the 1991 Gulf War, also known as Operation Desert Storm. But the end of the war signaled the beginning of a new struggle for thousands of service men and women—their personal battle with Gulf War illness (GWI).

This debilitating condition is estimated to affect more than 200,000 Desert Storm veterans, with studies indicating that few have recovered, or even substantially improved, in the 24 years since the war. The long-term effects have brought difficult challenges for veterans and their families, who continue to seek answers about the causes of GWI and treatments that can improve their health.

In a recent study published in the BMC journal Environmental Health, a Baylor University scientist has identified a significant link between GWI and a genetic factor that can render some individuals more susceptible to adverse effects of certain chemicals.

The study found that veterans with identified variants of the butyrylcholinesterase (BChE) gene were 40 times more likely to have GWI if they took an anti-nerve gas pill called pyridostigmine bromide (PB) during the war, compared to veterans with similar genes who did not take the pill.

The study provides the first direct evidence of a specific gene-exposure interaction in veterans’ risk for GWI.

Epidemiologist Lea Steele, Ph.D., research professor in Baylor’s Institute of Biomedical Studies and the study’s lead author, said the study can help explain why some veterans developed GWI in connection with their service in the 1991 conflict, while others who served alongside them remained healthy.

“It has long been known that genetic differences can produce differences in how individuals metabolize certain chemicals,” Steele said. “These results are important because they identify a specific genetic factor that would plausibly put veterans at increased risk for GWI in connection with a chemical to which personnel were widely exposed during the Gulf War.”

Previous studies have determined that GWI is not the result of combat stress and that evidence most consistently implicates chemical exposures during deployment. The 1991 Gulf War was the only conflict in which hundreds of thousands of U.S. troops took PB as a protective measure against the possible deadly effects of chemical nerve agents. Chemical weapons were thought to pose a risk to U.S. military personnel during the brief 1991 war because of their recent use in the region by Saddam Hussein’s Iraqi forces.

The most prominent GWI risk factors identified by studies of Gulf War veterans include taking PB and exposure to certain pesticides that can exert toxic effects on the brain and nervous system. The body’s natural defenses against these compounds include BChE and other enzymes that can neutralize the toxicants and protect against adverse effects. The Baylor study compared BChE in 144 veterans with GWI and 160 healthy veterans, and probed specifically to find out if the association of GWI with PB differed with BChE genetic type.

For the majority of veterans, who had the most common forms of BChE, use of PB was associated with a nearly three-fold increased risk for GWI. The risk was dramatically higher, however, for the nine percent of veterans with genetic forms of BChE that provide reduced enzyme protection. Veterans with these less active forms of BChE were 40 times more likely to have GWI if they used PB during the Gulf War, compared to those who did not use PB.

Steele cautioned that these findings can only be considered preliminary, since the study is the first to report this genetic association and included a relatively small number of veterans. She emphasized that the specific genetic link identified by the study would apply only to the subgroup of veterans with “at risk” BChE genotypes and would not explain other cases of GWI.

“It is important to evaluate this in a larger group of Gulf War veterans to determine if it can be replicated and provide more information about how many veterans were affected,” Steele said.

She noted that the gene-exposure interaction identified by the study is consistent with previous suggestions that genetic differences in BChE and other protective enzymes are important for understanding the long-term health effects of chemicals encountered by military personnel during Gulf War deployment.

Gulf War illness refers to the complex of chronic symptoms that affect veterans of the Gulf War at excess rates, but are not explained by routine clinical diagnoses or laboratory tests. Gulf War illness is characterized by multiple concurrent symptoms that typically include persistent headache, widespread pain, memory and concentration difficulties, fatigue, and digestive and other abnormalities.

Steele is the director of the Veterans Health Research Program at the Baylor Institute of Biomedical Studies. Study co-authors include Oksana Lockridge, Ph.D., of the Eppley Institute at the University of Nebraska Medical Center; Mary M. Gerkovich, Ph.D., of the University of Missouri-Kansas City School of Medicine; and Mary R. Cook, Ph.D., and Antonio Sastre, Ph.D., formerly of Midwest Research Institute (now MRI Global) of Kansas City, Mo.

ABOUT BAYLOR UNIVERSITY

Baylor University is a private Christian University and a nationally ranked research institution, characterized as having “high research activity” by the Carnegie Foundation for the Advancement of Teaching. The University provides a vibrant campus community for approximately 15,000 students by blending interdisciplinary research with an international reputation for educational excellence and a faculty commitment to teaching and scholarship. Chartered in 1845 by the Republic of Texas through the efforts of Baptist pioneers, Baylor is the oldest continually operating University in Texas. Located in Waco, Baylor welcomes students from all 50 states and more than 80 countries to study a broad range of degrees among its 11 nationally recognized academic divisions. Baylor sponsors 19 varsity athletic teams and is a founding member of the Big 12 Conference.

Looking for more news from Baylor University?